CXCL12 and neoplasm: On the other hand, in mice models, by subtracting the FAP-positive CAFs and by inhibiting cytokines, such as SDF-1, the resulting immune control of tumor growth and the efficacy of immunotherapy are accelerated in pancreatic cancer [188].